Dermata Therapeutics Announces Presentation of Abstract at the European Academy of Dermatology and Venereology Congress 2025
- Abstract highlights additional primary and secondary data from Phase 3 STAR-1 clinical study of XYNGARI™ for the treatment of...
BioSonic Bloom: What Published Research Says About 528 Hz and 432 Hz Audio Frequency Programs